Evidence map›Paper›PMID 19885996›Full record

Trial reportCritical care medicine2009

Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.

Mark P Yeager, Athos J Rassias, Patricia A Pioli, Michael L Beach, Kathleen Wardwell, Jane E Collins, Hong-Kee Lee, Paul M Guyre

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Critical care medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Oxidative Stress after Surgery on the Immature Heart.Oxidative medicine and cellular longevity · 2016
    Review
  14. Article
  15. Relative Adrenal Insufficiency in Pediatric Septic Shock.Journal of pediatric intensive care · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mark P YeagerDepartment of Anesthesiology and Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. Mark.P.Yeager@Hitchcock.Org
Athos J Rassias
Patricia A Pioli
Michael L Beach
Kathleen Wardwell
Jane E Collins
Hong-Kee Lee
Paul M Guyre
Dartmouth–Hitchcock Medical Center · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
VASCULAR LEUKOCYTES: BASIC IMMUNOBIOLOGY AND FUNCTIONAL PLASTICITYP20RR016437 · NCRR · DARTMOUTH COLLEGE · PI GREEN, WILLIAM R · 2001 to 2010
$24.3M
Glucocorticoid/cytokine mechanisms in endotoxemia.R01AI051547 · NIAID · DARTMOUTH COLLEGE · PI GUYRE, PAUL · 2003 to 2007
$1.9M
NCI NIH HHS P30 CA023108NCRR NIH HHS P20 RR016437NCRR NIH HHS P20RR016437NIAID NIH HHS AI051547NIAID NIH HHS R01 AI051547
6 · The paper itself

Abstract

objectiveThere is continuing controversy regarding the effect of glucocorticoids on a systemic inflammatory process. Based ona model of glucocorticoid action that includes both pro- and anti-inflammatory effects, we used the human experimental endotoxemia model to test the hypothesis that a transient elevation of plasma cortisol to stress-associated levels would enhance a subsequent (delayed) systemic inflammatory response to bacterial endotoxin.

designProspective, randomized, double-blind, placebo-controlled clinical investigation.

settingAcademic medical center. SUBJECTS: Thirty-six healthy human volunteers.

interventionsParticipants were randomized to receive a 6-hr intravenous infusion of saline (control), an intermediate dose of cortisol (Cort80; 6.3 mg/hr/70 kg), or a high dose of cortisol (Cort160; 12.6 mg/hr/70 kg) on day 1. On day 2, participants received an intravenous injection of 2 ng/kg Escherichia coli endotoxin followed by serial measurements of plasma cytokine concentrations. MEASUREMENTS AND MAIN

resultsBaseline participant characteristics and cortisol and cytokine concentrations were similar in all three groups. The plasma cortisol response to endotoxemia on day 2 was similar in all three groups. The interleukin-6 response to endotoxemia was significantly increased in the Cort80 Group compared with the control Group (p = .004), whereas the interleukin-10 response was significantly suppressed (p = .034). Corresponding results for the Cort160 Group were not significantly different from control Group values.

conclusionsIn this study, transient elevation of in vivo cortisol concentrations to levels that are observed during major systemic stress enhanced a subsequent, delayed in vivo inflammatory response to endotoxin. This appeared to be a dose-dependent effect that was more prominent at intermediate concentrations of cortisol than at higher concentrations of cortisol.

Indexed as

Leukocyte CountAdrenocorticotropic HormoneAdultAnti-Inflammatory AgentsC-Reactive ProteinCytokinesDose-Response Relationship, DrugEndotoxinsEscherichia coliFemaleHumansHydrocortisoneInfusions, IntravenousInterleukin-10Interleukin-6MaleAdrenocorticotropic HormoneAnti-Inflammatory AgentsC-Reactive ProteinCytokinesEndotoxinsHydrocortisonehydrocortisone hemisuccinateInterleukin-10Interleukin-6

Identifiers

PMID19885996
PMCPMC2819133
OpenAlexW2016325551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.